Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin for inflammatory markers and hemodynamic progression in degenerative aortic stenosis
2005-003666-42Phase 4Active
- Sponsor
- Fundación Castellano-Leonesa de Cardiología
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in aortic stenosis (AS) comparing Lescol Prolib with Placebo (2 arms). Primary endpoints: Change in C-reactive protein, Change in other inflammatory markers and 2 more. Started May 2006; status: active.
02
Drugs
fluvastatin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2005-003666-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003666-42.